布法林
化学
糖苷
糖基化
葡萄糖苷
溶解度
亲脂性
产量(工程)
酶
色谱法
有机化学
立体化学
生物化学
医学
细胞凋亡
材料科学
替代医学
病理
冶金
作者
Yan Liu,Wei Xü,Zhaohe Huang,Jun Guo,Ren‐Wang Jiang
标识
DOI:10.1002/cbdv.202000529
摘要
Abstract In this study, bufalin was glycosylated by an efficient chemo‐enzymatic strategy. Firstly, 2‐chloro‐4‐nitrophenyl‐1‐ O ‐ β‐ D‐glucoside (sugar donors) was obtained by chemical synthesis. Then, the glycosylation of the bufalin was achieved with the synthesized sugar donor under the catalysis of two glycosyltransferases (Loki and ASP). Finally, two glycosides, i. e., bufalin‐3‐ O ‐ β ‐D‐glucopyranoside and bufalin‐3‐ O ‐[ β ‐D‐glucopyranosyl‐(1→2)‐ β ‐D‐glucopyranoside)], were obtained by preparative HPLC. Compared to our previously reported sole chemical (total yield 10 % in four steps) or enzymatic methods (30 %), our combined chemo‐enzymatic strategy in this article greatly improves the yields of monoglycoside (68 %) and diglycoside (21 %) and decreased the experimental cost (90 %). Furthermore, we tested the water solubility of these glycosides and found that the water solubilities of the two glycosides were 13.1 and 53.7 times of bufalin, respectively. In addition, the inhibitory activity of these glycosides against Na + , K + ‐ATPase were evaluated. The mono‐glycosylated compound showed more potent activity than bufalin, while the diglycosylated compound was less potent.
科研通智能强力驱动
Strongly Powered by AbleSci AI